Skip to main content
BON logo

Bon Natural Life Limited (BON) Stock Price & Analysis

Bon Natural Life Limited (BON) — MoonshotScore 39/100 (Weak band), calculated Nov 18, 2026. Price $1.04 (-0.95%), as of the Nov 19, 2026 trading session; market cap $8.50M.

Educational signal · not a buy or sell recommendation · How to read this

$1.04 −$0.01 (-0.95%) Market Cap $8.50M

Bon Natural Life Limited · BON · NASDAQ

Bon Natural Life Limited specializes in the innovation, production, and global distribution of active functional compounds derived from natural plant extracts. The company supplies these ingredients to industrial clients in the personal care, health, food, and pharmaceutical sectors across China and international markets.

Price as of Nov 19, 2026

Key Statistics

39 of 100

MoonshotScore v2 · Bon Natural Life (BON)

Weak
Business Quality Poor (14)
Financial Safety Strained (37)
Valuation Cheap (85)
Growth Durability Shrinking (1)
Momentum Quiet (46)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a strained balance sheet and stalling growth — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone. Business Quality: Poor; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Shrinking; Momentum: Quiet.

  • quarterly revenue $8M (Q2 FY2026, quarter ended Mar 2026)
  • EPS beat 2 of the last 6 reports
  • Altman Z 0.50 · Piotroski F 3

Holding back: weak fundamentals, soft growth

Helping: an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for BON (52 recorded, newest six shown)
RecordedScoreBand
40Weak
40Weak
40Weak
40Weak
39Weak
39Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$1.04
Change on the day-0.95%
Market capitalisation$8.50M—
Shares traded on the day13.6K

Price & events

Other perspectives

Council score for Bon Natural Life (BON): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Weak
Valuation Strong
Growth Durability Negative
Momentum Neutral

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Moderate
ROE Negative
Gross Margin Weak

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Bon Natural Life (BON), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Bon Natural Life Limited (BON) is listed on NASDAQ. It employs 96 people. In Q2 FY2026 it reported revenue of $8M and net income of -$9M. The market values it at $8.50M.

2 · Latest results

What do the latest results show for Bon Natural Life (BON)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $8M. Against analyst estimates the company has EPS beat 2 of the last 6 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$8M-$9M-$1.51 (diluted)
Q4 FY2025$11M-$2M-$0.79 (diluted)
Q2 FY2025$8M$169,227$0.50 (diluted)
Q4 FY2024$14M$408,691$0.22 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Bon Natural Life (BON)?

Short answer · as of

The MoonshotScore pillars rate an attractive price as strengths. What is holding it back is weak fundamentals, soft growth. The distress and quality screens read Altman Z 0.50 · Piotroski F 3. Trailing ratios: ROE -21.0% · ROA -14.2% · current ratio 1.83 · earnings yield -169.6% · free-cash-flow yield 32.6%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of 0.50 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-21.0%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 6 reported quarters.
5 · Peer comparison

How does Bon Natural Life compare with its peers?

Short answer

Bon Natural Life's score ranks 2nd of 2 in the bounded comparison shown, against 1 same-model peer. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Axalta Coating Systems Ltd. (AXTA) Same industry, near in market value$36.46 Nov 18, 2026$7.80B69 5-pillar Nov 18, 2026
Bon Natural Life (BON) — this page$1.04$8.50M39

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held BON in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported BON in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What Investors Ask About Bon Natural Life (BON)

These answers are editorial: 1 of these 9 answers is drawn from the BON research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for BON?

BON carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is BON a good stock to buy?

Stock Expert AI does not rate BON buy, sell or hold. Bon Natural Life Limited carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the BON stock price today?

The last price recorded for Bon Natural Life Limited (BON), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

How does Bon Natural Life Limited manage supply chain and input cost risks?

Bon Natural Life Limited faces ongoing challenges related to its supply chain and raw material input costs, as highlighted by existing insights.

What are the key factors to evaluate for BON?

Bon Natural Life Limited (BON) holds a MoonshotScore in the low range. Capitalizing on the Clean Label Trend: The "clean label" movement, emphasizing natural, recognizable, and minimal ingredients, is a powerful force across the food and beverage, personal care, and health supplement industries. Not financial advice.

How frequently does BON data refresh on this page?

BON's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven BON's recent stock price performance?

Bon Natural Life Limited (BON) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialization in natural plant extracts aligns with growing consumer demand for natural and organic products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BON overvalued or undervalued right now?

Bon Natural Life Limited (BON) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of BON?

Fractional-share availability for Bon Natural Life Limited (BON) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.